Joseph J. Victor
Executive Chairman and Interim CEO

Joe Victor joined the Purigen Biosystems board at the time of the Series A funding in March of 2016.  Mr. Victor is also a Venture Partner at 5AM Ventures, a leading venture capital firm with offices in San Francisco and Boston focused on building next-generation life science companies.  Prior to joining 5AM Ventures, Mr. Victor served as CEO of Startide Sciences, a 5AM Ventures portfolio company chartered to identify and develop innovative technologies in the Life Sciences research tools markets.  Prior to Startide, Mr. Victor served as CEO of DVS Sciences (acquired by Fluidigm), and Applied Precision (acquired by GE Healthcare).  He currently serves as Executive Chairman on the boards of 5AM portfolio companies Biodesy and Precision Nanosystems and on the boards of Glencoe Software and RareCyte. Mr. Victor also serves as an advisory board member to the Harvard Program in Therapeutic Science and the UC Davis Ecosystem for Biophotonics Innovation.  Prior to his eighteen years in Life Sciences, Mr. Victor held various executive management and technical positions in the high technology, aviation, and energy markets.  Mr. Victor holds an MBA from UCLA and MS and BS degrees in engineering from the University of Washington.

Klint Rose, PhD
CSO and Co-founder

Dr. Klint Rose co-founded Purigen Biosystems in 2012. Dr. Rose was previously an R&D Manager at QuantaLife, Inc. (acquired by Bio-Rad), where he played a key leadership role in the development, launch, and support of their droplet digital PCR product. He previously directed a portfolio of several successful projects at Lawrence Livermore National Laboratory (LLNL) with applications in sample preparation, desalination, and nanomanufacturing. Dr. Rose is an expert in microfluidics and electrokinetics, with over 15 years of experience in the space. Klint received his B.S. and M.S. in mechanical engineering from the Massachusetts Institute of Technology (MIT) and his Ph.D. from Stanford University.

LinkedIn link:

Amy Hiddessen, PhD
CTO and Co-founder

Dr. Amy Hiddessen has served as CTO for Purigen since its founding in 2012. Dr. Hiddessen was previously Director of Product Development at QuantaLife, Inc. (acquired by Bio-Rad), where she led the ddPCR emulsion chemistry and instrumentation from the early stages of R&D through successful product commercialization. Prior to QuantaLife, Dr. Hiddessen directed multiple cell biology and biomolecular detection projects as Principal Investigator of her own lab at Lawrence Livermore National Laboratory. She has over 15 years of experience developing innovative chemistries and tools for life and materials sciences applications, resulting in numerous patents and publications. Amy received her B.S. in chemical engineering from Stanford University, and M.S. and Ph.D. degrees in chemical engineering at the University of Pennsylvania.

LinkedIn Link:

Steve Reichenbach

Steve Reichenbach brings over 30 years of financial and operational experience to his role at Purigen. Mr. Reichenbach was the CFO at Flow International for 13 years before joining Applied Precision Inc., which was acquired by GE Healthcare. Steve serves as a board member for several life science start-ups.

LinkedIn Link:

Pam Delucchi
Senior Vice President of Operations

Pam Delucchi has over 25 years of experience in the life science industry in both startup and large company environments. Ms. Delucchi was previously the Vice President of the Global Reagents Business at Fluidigm. Prior to joining Fluidigm, she was Vice President of Operations at DVS Sciences (acquired by Fluidigm in 2014), Vice President Operations and Quality at Panomics (acquired bv Affymetrix in 2008), and Director of Manufacturing and Program Management at Clontech Laboratories, Inc. (acquired by BDBiosciences in 2000). Pam received her M.S. in Microbiology and Genetic Engineering from San Francisco State University.

LinkedIn Link:


Joe Victor
Executive Chairman of the Board of Directors


Andrew Schwab
Managing Partner – 5AM Ventures


Mitchell Mutz, PhD
Investment Director – Roche Venture Fund


Bill W. Colston, PhD
CEO of HealthTell, Inc.


Amy Hiddessen, PhD
Purigen CTO and Co-founder


Klint Rose, PhD
Purigen CSO and Co-founder



Juan Santiago, PhD
Scientific Advisor and Co-founder

Dr. Santiago is the inventor of Purigen’s proprietary technology, and currently acts as a Scientific Advisor to the company. He is Professor and Chair of the Thermosciences Group of Mechanical Engineering at Stanford University. He received his PhD in Mechanical Engineering from the University of Illinois at Urbana-Champaign in 1995. His research includes the development of microsystems for on-chip chemical and biochemical analysis. He was a co-founder of Cooligy, Inc. which brought to market the first mass production liquid cooling system for desktop computers, and which was purchased by Emerson Network Power. He has authored and co-authored 130 archival publications and 200 conference papers, and holds 25 patents.

Research Page Link: